TPX2的表达对胰腺癌预后的影响

doi:10.16352/j.issn.1001-6325.2023.06.0875

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (6): 875-881.doi: 10.16352/j.issn.1001-6325.2023.06.0875

TPX2的表达对胰腺癌预后的影响

苏靓誉¹, 张振西¹, 杜文静^1,2*

1.中国医学科学院基础医学研究所北京协和医学院基础学院细胞生物学系医学分子生物学国家重点实验室,北京 100005;
2.山西医科大学基础医学院细胞生理学教育部重点实验室,山西太原 030606

收稿日期:2023-02-22 修回日期:2023-03-28 出版日期:2023-06-05 发布日期:2023-05-31
通讯作者: ^*wenjingdu@ibms.pumc.edu.cn
基金资助:
国家重点研发计划(2019YFA0802600);中国医学科学院医学与健康科技创新工程 (2021-I2M-1-016);细胞生态海河实验室项目(22HHXBSS0011);中国医学科学院医学与健康科技创新工程健康长寿先导科技专项(2019-RC-HL-007)

Effect of TPX2 expression on prognosis of pancreatic carcinoma

SU Jingyu¹, ZHANG Zhenxi¹, DU Wenjing^1,2*

1. State Key Laboratory of Medical Molecular Biology,Department of Cell Biology,Institute of Basic Medical Sciences CAMS, School of Basic Medicine PUMC,Beijing 100005;
2. Key Laboratory of Cell Physiology, Ministry of Education, College of Basic Medicine,Shanxi Medical University, Taiyuan 030606,China

Received:2023-02-22 Revised:2023-03-28 Online:2023-06-05 Published:2023-05-31
Contact: ^*wenjingdu@ibms.pumc.edu.cn

摘要/Abstract

摘要： 目的研究Xklp2靶蛋白(TPX2)在胰腺癌中的表达情况及其预测预后的潜在价值。方法基于200个糖酵解代谢相关基因,从TCGA和GEO数据库获取胰腺患者的信息,对后者的糖酵解代谢特征进行评价,同时综合患者代谢特征及差异基因,采用Cox回归和Lasso回归分析建立风险模型,获得关键糖酵解相关基因TPX2,并用GEO数据库验证该模型的预后有效性。基于预后基因的表达分析胰腺癌患者的生存期,并分析正常胰腺组织和胰腺癌中预后基因的表达差异,最后在细胞水平验证预后基因的功能。结果病例队列被分为高、中、低3个糖酵解代谢特征组,低速率糖酵解代谢患者存在一定生存优势,TPX2是该模型的关键基因,胰腺癌患者显示高表达TPX2,具有较差的预后。细胞水平上敲降TPX2可抑制胰腺癌细胞增殖和集落形成。结论本研究基于糖酵解代谢模型有效地预测了胰腺癌患者的预后,TPX2有望成为胰腺癌预后预测的潜在标志性基因。

关键词: TPX2, 糖酵解, 胰腺癌, 增殖

Abstract: Objective To study the expression of Xklp2 target protein (targeting protein for Xenopus kinesin-like protein2, TPX2) in pancreatic carcinoma and its potential value in predicting prognosis. Methods Based on 200 genes related to glycolysis, the information of pancreatic patients was obtained from TCGA and GEO databases, and the characteristics of glycolysis metabolism of the latter were evaluated. At the same time, the metabolic characteristics and differential genes of the patients were evaluated, the risk model was established by Cox regression and Lasso regression analysis, and the key glycolysis related gene TPX2 was obtained. The prognostic validity of the model was verified by GEO database based on the expression of prognostic genes, the overall survival (OS) of patients with pancreatic cancer, the difference in the expression of prognostic genes between normal pancreatic tissue and pancreatic cancer was analyzed and finally the function of prognostic genes was verified at the cellular level. Results The case cohort was divided into three characteristic groups: high, medium and low glycolysis metabolism. Patients with low-rate glycolysis metabolism had certain survival advantages. TPX2 was the key gene of this model. Pancreatic cancer patients showed high expression of TPX2 and had poor prognosis. Knocking down TPX2 at cellular level can inhibit the proliferation and colony formation of pancreatic cancer cells. Conclusions The model based on glycolysis metabolism can effectively predict the prognosis of patients with pancreatic cancer. TPX2 is expected to become a potential marker gene for predicting the prognosis of pancreatic cancer.

Key words: TPX2, glycolysis, pancreatic carcinoma, proliferation

中图分类号:

R735.9

苏靓誉, 张振西, 杜文静. TPX2的表达对胰腺癌预后的影响[J]. 基础医学与临床, 2023, 43(6): 875-881.

SU Jingyu, ZHANG Zhenxi, DU Wenjing. Effect of TPX2 expression on prognosis of pancreatic carcinoma[J]. Basic & Clinical Medicine, 2023, 43(6): 875-881.

参考文献 10

[1]	Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States[J]. Cancer Res, 2014,74:2913-2921.
[2]	Sui C,Song Z,Yu H,et al. Prognostic significance of TPX2 and NIBP in esophageal cancer[J]. Oncol Lett,2019,18:4221-4229.
[3]	Long N, Chu L, Jia J, et al. CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells[J]. Cancer Cell Int, 2020,20:374.doi:10.1186/s12935-020-01454-x.
[4]	Zhang B, Zhang M, Li Q, et al. TPX2 mediates prostate cancer epithelial-mesenchymal transition through CDK1 regulated phosphorylation of ERK/GSK3β/SNAIL pathway[J]. Biochem Biophys Res Commun, 2021,546:1-6.
[5]	Taherdangkoo K, Kazemi Nezhad SR, Hajjari MR, et al. miR-485-3p suppresses colorectal cancer via targeting TPX2[J]. Bratisl Lek Listy, 2020,121:302-307.
[6]	Warburg O. On the origin of cancer cells[J]. Science, 1956, 123: 309-314.
[7]	Yan L,Li Q,Yang J,et al. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation,invasion,and tumor growth of bladder cancer[J]. J Cell Biochem,2018,119:1791-1803.
[8]	Yang Y, Li DP, Shen N, et al. TPX2 promotes migration and invasion of human breast cancer cells[J]. Asian Pac J Trop Med, 2015,8:1064-1070.
[9]	Koike Y, Yin C, Sato Y, et al. TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma[J]. Oncol Lett, 2022,23:136. doi: 10.3892/ol.2022.13256.
[10]	Chaika NV, Yu F, Purohit V, et al. Differential expres-sion of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocar-cinoma[J]. PLoS One, 2012,7:e32996. doi: 10.1371/journal.pone.0032996.

[1]	肖艳红, 姜明东, 林叶远, 冉灿, 梁博. 灯盏花乙素抑制人前列腺癌细胞系PC-3的增殖和迁移[J]. 基础医学与临床, 2024, 44(9): 1229-1235.
[2]	姚安军, 陈凌子, 金惠仙. 二十二碳六烯酸抑制人结肠癌细胞系HT-29增殖[J]. 基础医学与临床, 2024, 44(8): 1107-1112.
[3]	郑红, 陈晓霞, 韩李周, 陈苗, 皇甫娟. 降低lncRNA-RMRP表达抑制人肺癌细胞系A549的增殖和侵袭[J]. 基础医学与临床, 2024, 44(7): 974-978.
[4]	曹清文, 祁琳, 禹博, 田晨晨, 袁海宁, 王越. 红景天苷促进人血管内皮细胞系EA.hy926增殖与迁移[J]. 基础医学与临床, 2024, 44(7): 925-930.
[5]	张鹏举, 李杰, 张梦迪, 孙少科, 许寅喆. KAT8通过增强METTL3表达促进结直肠癌细胞系增殖[J]. 基础医学与临床, 2024, 44(7): 931-939.
[6]	高寅洁, 童安莉. 醛固酮产生腺瘤中细胞死亡和增殖机制[J]. 基础医学与临床, 2024, 44(6): 758-762.
[7]	段然, 李青原, 冯同. 代谢重编程在特发性肺纤维化发病中的作用[J]. 基础医学与临床, 2024, 44(6): 882-886.
[8]	王婷婷, 萧宁, 林佃新, 董海涛. 大蒜素抑制口腔癌细胞系CAL27的增殖[J]. 基础医学与临床, 2024, 44(5): 673-676.
[9]	张迪雅, 李云帆, 郭泓江, 仇佳星, 王钰铖, 鞠瑞, 郭磊. 胶质瘤条件培养基促进巨噬细胞糖酵解及表型转化[J]. 基础医学与临床, 2024, 44(5): 599-605.
[10]	贾安娜, 郭金鑫, 张璇, 战世佳, 于永波, 郭永丽, 常艳. TMEFF1对神经母细胞瘤细胞系增殖的调控[J]. 基础医学与临床, 2024, 44(5): 637-644.
[11]	梁香存, 魏小雨, 梁健, 王庆, 耿广. 安罗替尼通过调控miR-16-5p/PD-1轴抑制人非小细胞肺癌细胞系增殖并促进凋亡[J]. 基础医学与临床, 2024, 44(4): 503-512.
[12]	陆凯, 陆建菊, 郭文利, 黄建棋, 李志华. lncRNA VIM-AS5在人乳腺癌细胞系中的表达及对乳腺癌细胞增殖和迁移的影响[J]. 基础医学与临床, 2024, 44(4): 447-453.
[13]	郭泓江, 徐也婷, 张迪雅, 仇佳星, 王钰铖, 鞠瑞, 郭磊. 羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响[J]. 基础医学与临床, 2024, 44(4): 440-446.
[14]	李娜, 李涛, 杨冬梨, 姚媛. 和厚朴酚抑制人脂肪间充质干细胞增殖[J]. 基础医学与临床, 2024, 44(4): 483-488.
[15]	张婧, 杨自更, 蔡文琴, 曹维维, 韦红梅, 薛茜茜, 吴宾. 抑制抗增殖蛋白2增强非小细胞肺癌细胞系A549对厄洛替尼敏感性[J]. 基础医学与临床, 2024, 44(3): 325-332.

TPX2的表达对胰腺癌预后的影响

Effect of TPX2 expression on prognosis of pancreatic carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 10

相关文章 15

编辑推荐

Metrics

本文评价